|
|
Article: Pneumococcal conjugate vaccine safe for low-birth-weight and preterm infants.(Brief Article)
- Article from:
- Vaccine Weekly
- Article date:
- May 15, 2002
- Author:
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 MAY 15 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Researchers in the U.S. found heptavalent CRM197 pneumococcal vaccine (PCV) as safe and effective as the meningococcal type C conjugate vaccine (MCV) for protecting low-birth-weight and preterm infants against invasive pneumococcal disease.
H. Shinefield of the Kaiser Permanente Vaccine Study Center, Oakland, California and colleagues followed 37,868 infants enrolled in a randomized double blind clinical trial to compare the safety, efficacy, and immunogenicity of the PCV and MCV. Of the total number of children, 1756 were identified as low birth weight (between 750 ...